Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - reuben+shaw
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Dual-Action Inhibition Strategy for KRAS and LKB1 Mutant NSCLC
NU 2023-113 INVENTORS Lillian Eichner (Feinberg School of Medicine, Department of Biochemistry and Molecular Genetics)*
Reuben Shaw
(Salk Institute) SHORT DESCRIPTION A dual drug combination to target KRAS and LKB1 mutant non–small cell lung cancer that results in superior efficacy by enhancing T cell recruitment and reducing tumor burden. BACKGROUND Lung...
Published: 4/29/2026
|
Updated: 4/29/2026
|
Inventor(s):
Reuben Shaw
Keywords(s):
Cancer/Oncology
,
Lung cancer
,
Repurposed Drugs
,
Small molecule
,
Therapeutics
Category(s):
Life Sciences > Therapeutics